[1] |
Al-Swiahb JN,Chen CH,Chuang HC,et al. Clinical,pathological and molecular determinants in squamous cell carcinoma of the oral cavity[J]. Future Oncol,2010,6(5):837-850.
|
[2] |
Agarwal JP,Nemade B,Murthy V,et al. Hypofractionated,palliative radiotherapy for advanced head and neck cancer[J]. Radiother Oncol,2008,89(1):51-56.
|
[3] |
Das S,Thomas S,Pal SK,et al. Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer:CMC Vellore experience[J]. Indian J Palliat Care,2013,19(2):93-98.
|
[4] |
Mohanti BK,Umapathy H,Bahadur S,et al. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer:AIIMS study[J]. Radiother Oncol,2004,71(3):275-280.
|
[5] |
Calais G,Alfonsi M,Bardet E,et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma[J]. J Natl Cancer Inst,1999,91(24):2081-2086.
|
[6] |
Meng J,Meng QF,Gu QP,et al. Radioactive seed implantation combined with prosthesis denture in treatment of oral and maxillofacial malignancy[J]. Cell Biochem Biophys,2013,67(3):1529-1532.
|
[7] |
王兴,孟箭. 125I植入联合尼妥珠单抗治疗头颈部恶性肿瘤的近期疗效及安全性评价[J/CD]. 中华临床医师杂志:电子版,2013,7(13):6152-6154.
|
[8] |
Gomez-Roca C,Koscielny S,Ribrag V,et al. Tumour growth rates and RECIST criteria in early drug development[J]. Eur J Cancer,2011,47(17):2512-2516.
|
[9] |
Denis F,Garaud P,Bardet E,et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma:comparison of LENT/SOMA,RTOG/EORTC,and NCI-CTC scoring systems[J]. Int J Radiat Oncol Biol Phys,2003,55(1):93-98.
|
[10] |
Ahn JS,Cho SH,Kim OK,et al. The efficacy of an induction chemotherapy combination with docetaxel,cisplatin,and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer[J]. Cancer Res Treat,2007,39(3):93-98.
|
[11] |
Semrau S,Schmidt D,Lell M,et al. Results of chemoselection with short induction chemotherapy followed by chemoradiationor surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx[J]. Oral Oncol,2013,49(5):454-460.
|
[12] |
Lyman GH,Dale DC,Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy:a nationwide study of community practices[J]. J Clin Oncol,2003,21(24):4524-4531.
|
[13] |
Jiang YL,Meng N,Wang JJ,et al. Percutaneous computed tomography/ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck[J]. Cancer Biol Ther,2010,9(12):959-966.
|
[14] |
Ruge MI,Simon T,Suchorska B,et al. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children:long-term outcome[J]. J Clin Oncol,2011,29(31):4151-4159.
|
[15] |
Ruge MI,Kickingereder P,Grau S,et al. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades Ⅱ and Ⅲ gliomaslocated in the central sulcus region[J]. Neuro Oncol,2013,15(12):1721-1731.
|
[16] |
王兴,孟箭. 125I粒子植入治疗高龄非霍奇金淋巴瘤并吞咽困难一例[J]. 中华全科医师杂志,2015,14(5):388-389.
|
[17] |
Khalilur R,Hayashi K,Shibuya H. Brachytherapy for tongue cancer in the very elderly is an alternative to external beamradiation[J]. Br J Radiol,2011,84(1004):747-749.
|
[18] |
Zhang L,Chen LH,Wang J,et al. CT-guided radioactive 125I seed implantation treatment of multiple pulmonary metastases of hepatocellular carcinoma[J]. Clin Radiol,2014,69(6):624-629.
|
[19] |
Jiang YL,Meng N,Wang JJ,et al. CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers[J]. Radiat Oncol,2010(5):68.
|
[20] |
Zheng L,Zhang J,Zhang J,et al. Preliminary results of 125I interstitial brachytherapy for locally recurrent parotidgland cancer in previously irradiated patients[J]. Head Neck,2012,34(10):1445-1449.
|